Novartis Consumer Health Changes Leave CHPA Without A Chair
This article was originally published in The Tan Sheet
Executive Summary
Novartis exec Michel Orsinger has taken the reigns as head of the firm's consumer health global OTC division, effective Jan. 1
You may also be interested in...
Valentino joins Alpharma
Michael Valentino steps into newly created role of president & COO of Global Human Pharmaceuticals and exec VP of firm effective Oct. 15. He reports to Alpharma President & CEO Ingrid Wiik, who says Valentino will help to develop firm's "global growth opportunities by creating and expanding key strategic alliances [and] developing a strong global new product pipeline." Valentino most recently served as Novartis Consumer Health global head/exec VP and also was chairman of CHPA's board (1"The Tan Sheet" Jan. 7, 2002, p. 3)...
Valentino joins Alpharma
Michael Valentino steps into newly created role of president & COO of Global Human Pharmaceuticals and exec VP of firm effective Oct. 15. He reports to Alpharma President & CEO Ingrid Wiik, who says Valentino will help to develop firm's "global growth opportunities by creating and expanding key strategic alliances [and] developing a strong global new product pipeline." Valentino most recently served as Novartis Consumer Health global head/exec VP and also was chairman of CHPA's board (1"The Tan Sheet" Jan. 7, 2002, p. 3)...
Valentino joins Alpharma
Michael Valentino steps into newly created role of president & COO of Global Human Pharmaceuticals and exec VP of firm effective Oct. 15. He reports to Alpharma President & CEO Ingrid Wiik, who says Valentino will help to develop firm's "global growth opportunities by creating and expanding key strategic alliances [and] developing a strong global new product pipeline." Valentino most recently served as Novartis Consumer Health global head/exec VP and also was chairman of CHPA's board (1"The Tan Sheet" Jan. 7, 2002, p. 3)...